{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetes", "hyperglycemia", "medicinal plants", "phytotherapy"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29300317", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "03"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "01", "Day": "04"}], "Language": ["eng"], "ELocationID": ["105", "10.3390/molecules23010105"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jan", "Day": "04"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Phytotherapy in the Management of Diabetes: A Review.", "Abstract": {"AbstractText": ["Phytotherapy has long been a source of medicinal products and over the years there have been many attempts to use herbal medicines for the treatment of diabetes. Several medicinal plants and their preparations have been demonstrated to act at key points of glucidic metabolism. The most common mechanisms of action found include the inhibition of \u03b1-glucosidase and of AGE formation, the increase of GLUT-4 and PPARs expression and antioxidant activity. Despite the large amount of literature available, the actual clinical effectiveness of medicinal plants in controlling diabetes-related symptoms remains controversial and there is a crucial need for stronger evidence-based data. In this review, an overview of the medicinal plants, which use in the management of diabetes is supported by authoritative monographs, is provided. References to some species which are currently under increasing clinical investigation are also reported."]}, "AuthorList": [{"Identifier": ["0000-0002-5976-780X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. paolo.governa@unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. paolo.governa@unisi.it."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. paolo.governa@unisi.it."}], "LastName": "Governa", "ForeName": "Paolo", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. baiocca89@gmail.com."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. baiocca89@gmail.com."}], "LastName": "Baini", "ForeName": "Giulia", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. borgonetti@student.unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. borgonetti@student.unisi.it."}], "LastName": "Borgonetti", "ForeName": "Vittoria", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. giugiucettola@gmail.com."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. giugiucettola@gmail.com."}], "LastName": "Cettolin", "ForeName": "Giulia", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. daniela.giachetti@unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. daniela.giachetti@unisi.it."}], "LastName": "Giachetti", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. annarosa.magnano@unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. annarosa.magnano@unisi.it."}], "LastName": "Magnano", "ForeName": "Anna Rosa", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. elisabetta.miraldi@unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. elisabetta.miraldi@unisi.it."}], "LastName": "Miraldi", "ForeName": "Elisabetta", "Initials": "E"}, {"Identifier": ["0000-0003-2997-4178"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Via Laterina 8, 53100 Siena, Italy. biagi4@unisi.it."}, {"Identifier": [], "Affiliation": "Italian Society of Phytotherapy, Via Laterina 8, 53100 Siena, Italy. biagi4@unisi.it."}], "LastName": "Biagi", "ForeName": "Marco", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": ["methods"], "DescriptorName": "Ethnobotany"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gale E.A.M. The myth of the metabolic syndrome. Diabetologia. 2005;48:1679\u20131683. doi: 10.1007/s00125-005-1873-5.", "ArticleIdList": ["10.1007/s00125-005-1873-5", "16025251"]}, {"Citation": "Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289\u20132304. doi: 10.2337/diacare.28.9.2289.", "ArticleIdList": ["10.2337/diacare.28.9.2289", "16123508"]}, {"Citation": "Reaven G.M. The metabolic syndrome: Requiescat in pace. Clin. Chem. 2005;51:931\u2013938. doi: 10.1373/clinchem.2005.048611.", "ArticleIdList": ["10.1373/clinchem.2005.048611", "15746300"]}, {"Citation": "Parikh R.M., Mohan V. Changing definitions of metabolic syndrome. Indian J. Endocrinol. Metab. 2012;16:7\u201312. doi: 10.4103/2230-8210.91175.", "ArticleIdList": ["10.4103/2230-8210.91175", "PMC3263200", "22276247"]}, {"Citation": "Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998;15:539\u2013553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.", "ArticleIdList": ["10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S", "9686693"]}, {"Citation": "Alberti K.G.M.M., Zimmet P., Shaw J. The metabolic syndrome\u2014A new worldwide definition. Lancet. 2005;366:1059\u20131062. doi: 10.1016/S0140-6736(05)67402-8.", "ArticleIdList": ["10.1016/S0140-6736(05)67402-8", "16182882"]}, {"Citation": "International Diabetes Federation.  [(accessed on 29 December 2017)]; Available online:  https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome."}, {"Citation": "Lam D.W., LeRoith D. Metabolic Syndrome. In: De Groot L.J., Chrousos G., Dungan K., Feingold K.R., Grossman A., Hershman J.M., Koch C., Korbonits M., McLachlan R., New M., et al., editors. Endotext. MDText.com, Inc.; South Dartmouth, MA, USA: 2000."}, {"Citation": "Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27:2676\u20132681. doi: 10.2337/diacare.27.11.2676.", "ArticleIdList": ["10.2337/diacare.27.11.2676", "15505004"]}, {"Citation": "O\u2019Neill S., O\u2019Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015;16:1\u201312. doi: 10.1111/obr.12229.", "ArticleIdList": ["10.1111/obr.12229", "25407540"]}, {"Citation": "Rochlani Y., Pothineni N.V., Mehta J.L. Metabolic Syndrome: Does it Differ between Women and Men? Cardiovasc. Drugs Ther. 2015;29:329\u2013338. doi: 10.1007/s10557-015-6593-6.", "ArticleIdList": ["10.1007/s10557-015-6593-6", "25994831"]}, {"Citation": "Kooti W., Farokhipour M., Asadzadeh Z., Ashtary-Larky D., Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: A systematic review. Electron. Physician. 2016;8:1832\u20131842. doi: 10.19082/1832.", "ArticleIdList": ["10.19082/1832", "PMC4768936", "26955456"]}, {"Citation": "Ota A., Ulrih N.P. An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes. Front. Pharmacol. 2017;8:1\u201314. doi: 10.3389/fphar.2017.00436.", "ArticleIdList": ["10.3389/fphar.2017.00436", "PMC5499308", "28729836"]}, {"Citation": "Tabatabaei-malazy O., Ramezani A., Atlasi R., Larijani B., Abdollahi M. Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus. J. Diabetes Metab. Disord. 2016;15:48. doi: 10.1186/s40200-016-0273-3.", "ArticleIdList": ["10.1186/s40200-016-0273-3", "PMC5073927", "27785446"]}, {"Citation": "Rios J.L., Francini F., Schinella G.R. Natural products for the treatment of type 2 Diabetes mellitus. Planta Med. 2015;81:975\u2013994. doi: 10.1055/s-0035-1546131.", "ArticleIdList": ["10.1055/s-0035-1546131", "26132858"]}, {"Citation": "Yeh G.Y., Eisenberg D.M., Kaptchuk T.J., Phillips R.S. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26:1277\u20131294. doi: 10.2337/diacare.26.4.1277.", "ArticleIdList": ["10.2337/diacare.26.4.1277", "12663610"]}, {"Citation": "Cefalu W.T., Stephens J.M., Ribnicky D.M. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. CRC Press/Taylor & Francis; Boca Raton, FL, USA: 2011. Diabetes and Herbal (Botanical) Medicine.", "ArticleIdList": ["22593924"]}, {"Citation": "Chawla R., Thakur P., Chowdhry A., Jaiswal S., Sharma A., Goel R., Sharma J., Priyadarshi S.S., Kumar V., Sharma R.K., et al. Evidence based herbal drug standardization approach in coping with challenges of holistic management of diabetes: A dreadful lifestyle disorder of 21st century. J. Diabetes Metab. Disord. 2013;12:35. doi: 10.1186/2251-6581-12-35.", "ArticleIdList": ["10.1186/2251-6581-12-35", "PMC7983574", "23822656"]}, {"Citation": "World Health Organization . WHO Monographs on Selected Medicinal Plants. Volume 1 World Health Organization; Geneva, Switzerland: 1999."}, {"Citation": "Farag M.A., Ali S.E., Hodaya R.H., El-Seedi H.R., Sultani H.N., Laub A., Eissa T.F., Abou-Zaid F.O.F., Wessjohann L.A. Phytochemical profiles and antimicrobial activities of Allium cepa Red cv. and A. sativum subjected to different drying methods: A comparative MS-based metabolomics. Molecules. 2017;22:761. doi: 10.3390/molecules22050761.", "ArticleIdList": ["10.3390/molecules22050761", "PMC6154556", "28481316"]}, {"Citation": "Augusti K.T. Studies on the effects of a hypoglycemic principle from Allium Cepa Linn. Indian J. Med. Res. 1973;61:1066\u20131071.", "ArticleIdList": ["4757998"]}, {"Citation": "Gupta R.K., Gupta S., Samuel K.C. Blood sugar lowering effect of various fractions of onion. Indian J. Exp. Biol. 1977;15:313\u2013314.", "ArticleIdList": ["914348"]}, {"Citation": "Jain R.C., Vyas C.R. Letter: Hypoglycaemia action of onion on rabbits. Br. Med. J. 1974;2:730. doi: 10.1136/bmj.2.5921.730-b.", "ArticleIdList": ["10.1136/bmj.2.5921.730-b", "PMC1611141", "4852817"]}, {"Citation": "Ogunmodede O.S., Saalu L.C., Ogunlade B., Akunna G.G., Oyewopo A.O. An Evaluation of the Hypoglycemic, Antioxidant and Hepatoprotective Potentials of Onion (Allium cepa L.) on Alloxan-induced Diabetic Rabbits. Int. J. Pharmacol. 2012;8:21\u201329."}, {"Citation": "El-Demerdash F.M., Yousef M.I., El-Naga N.I.A. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 2005;43:57\u201363. doi: 10.1016/j.fct.2004.08.012.", "ArticleIdList": ["10.1016/j.fct.2004.08.012", "15582196"]}, {"Citation": "Azuma K., Minami Y., Ippoushi K., Terao J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr. 2007;40:131\u2013140. doi: 10.3164/jcbn.40.131.", "ArticleIdList": ["10.3164/jcbn.40.131", "PMC2127222", "18188415"]}, {"Citation": "El-Soud N.A., Khalil M. Antioxidative effects of Allium Cepa essential oil in streptozotocin induced diabetic rats. Maced. J. Med. Sci. 2010;3:344\u2013351. doi: 10.3889/MJMS.1857-5773.2010.0118.", "ArticleIdList": ["10.3889/MJMS.1857-5773.2010.0118"]}, {"Citation": "Akash M.S.H., Rehman K., Chen S. Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus. Nutrition. 2014;30:1128\u20131137. doi: 10.1016/j.nut.2014.02.011.", "ArticleIdList": ["10.1016/j.nut.2014.02.011", "25194613"]}, {"Citation": "Taj Eldin I.M., Ahmed E.M., Elwahab H.M.A. Preliminary Study of the Clinical Hypoglycemic Effects of Allium cepa (Red Onion) in Type 1 and Type 2 Diabetic Patients. Environ. Health Insights. 2010;4:71\u201377.", "ArticleIdList": ["PMC2978938", "21079693"]}, {"Citation": "Bang M.-A., Kim H.-A., Cho Y.-J. Alterations in the blood glucose, serum lipids and renal oxidative stress in diabetic rats by supplementation of onion (Allium cepa. Linn) Nutr. Res. Pract. 2009;3:242\u2013246. doi: 10.4162/nrp.2009.3.3.242.", "ArticleIdList": ["10.4162/nrp.2009.3.3.242", "PMC2808725", "20090891"]}, {"Citation": "Ahmad W., Ijaz B., Shabbiri K., Ahmed F., Rehman S. Oxidative toxicity in diabetes and Alzheimer\u2019s disease: Mechanisms behind ROS/RNS generation. J. Biomed. Sci. 2017;24:76. doi: 10.1186/s12929-017-0379-z.", "ArticleIdList": ["10.1186/s12929-017-0379-z", "PMC5606025", "28927401"]}, {"Citation": "Campos K.E., Diniz Y.S., Cataneo A.C., Faine L.A., Alves M.J.Q.F., Novelli E.L.B. Hypoglycaemic and antioxidant effects of onion, Allium cepa: Dietary onion addition, antioxidant activity and hypoglycaemic effects on diabetic rats. Int. J. Food Sci. Nutr. 2003;54:241\u2013246. doi: 10.1080/09637480120092062.", "ArticleIdList": ["10.1080/09637480120092062", "12775373"]}, {"Citation": "Kim S.-H., Jo S.-H., Kwon Y.-I., Hwang J.-K. Effects of Onion (Allium cepa L.) Extract Administration on Intestinal \u03b1-Glucosidases Activities and Spikes in Postprandial Blood Glucose Levels in SD Rats Model. Int. J. Mol. Sci. 2011;12:3757\u20133769. doi: 10.3390/ijms12063757.", "ArticleIdList": ["10.3390/ijms12063757", "PMC3131588", "21747704"]}, {"Citation": "Gautam S., Pal S., Maurya R., Srivastava A.K. Ethanolic extract of Allium cepa stimulates glucose transporter typ 4-mediated glucose uptake by the activation of insulin signaling. Planta Med. 2015;81:208\u2013214. doi: 10.1055/s-0034-1396201.", "ArticleIdList": ["10.1055/s-0034-1396201", "25654406"]}, {"Citation": "Kumari K., Augusti K.T. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian J. Exp. Biol. 2002;40:1005\u20131009.", "ArticleIdList": ["12587728"]}, {"Citation": "Augusti K.I., Roy V.C., Semple M. Effect of allyl propyl disulphide isolated from onion (Allium cepa L.) on glucose tolerance of alloxan diabetic rabbits. Experientia. 1974;30:1119\u20131120. doi: 10.1007/BF01923642.", "ArticleIdList": ["10.1007/BF01923642", "4435106"]}, {"Citation": "World Health Organization . WHO Monographs on Selected Medicinal Plants. Volume 3 World Health Organization; Geneva, Switzerland: 2007."}, {"Citation": "Alzohairy M.A. Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evid. Based Complement. Altern. Med. 2016;2016:7382506. doi: 10.1155/2016/7382506.", "ArticleIdList": ["10.1155/2016/7382506", "PMC4791507", "27034694"]}, {"Citation": "Ekaidem I.S., Akpan H.D., Usoh I.F., Etim O.E., Ebong P.E. Effects of ethanolic extract of Azadirachta indica leaves on lipid peroxidation and serum lipids of diabetic Wistar rats. Acta Biol. Szeged. 2007;51:17\u201320."}, {"Citation": "Satyanarayana K., Sravanthi K., Shaker I.A., Ponnulakshmi R. Molecular approach to identify antidiabetic potential of Azadirachta indica. J. Ayurveda Integr. Med. 2015;6:165\u2013174. doi: 10.4103/0975-9476.157950.", "ArticleIdList": ["10.4103/0975-9476.157950", "PMC4630690", "26604551"]}, {"Citation": "Khosla P., Bhanwra S., Singh J., Seth S., Srivastava R.K. A study of hypoglycaemic effects of Azadirachta indica (Neem) in normal and alloxan diabetic rabbits. Indian J. Physiol. Pharmacol. 2000;44:69\u201374.", "ArticleIdList": ["10919098"]}, {"Citation": "Perez Gutierrez R.M., de Jesus Martinez Ortiz M. Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat. Pharm. Biol. 2014;52:1435\u20131444. doi: 10.3109/13880209.2014.895389.", "ArticleIdList": ["10.3109/13880209.2014.895389", "25026338"]}, {"Citation": "Gutierrez R.M.P., Gomez Y.G.Y., Guzman M.D. Attenuation of nonenzymatic glycation, hyperglycemia, and hyperlipidemia in streptozotocin-induced diabetic rats by chloroform leaf extract of Azadirachta indica. Pharmacogn. Mag. 2011;7:254\u2013259. doi: 10.4103/0973-1296.84243.", "ArticleIdList": ["10.4103/0973-1296.84243", "PMC3173902", "21969798"]}, {"Citation": "Kumar D.B., Mitra A., Manjunatha M. Azadirachtolide: An anti-diabetic and hypolipidemic effects from Azadirachta indica leaves. Pharmacogn. Commun. 2011;1:78\u201384. doi: 10.5530/pc.2011.1.5.", "ArticleIdList": ["10.5530/pc.2011.1.5"]}, {"Citation": "Ponnusamy S., Haldar S., Mulani F., Zinjarde S., Thulasiram H., RaviKumar A. Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents. PLoS ONE. 2015;10:e0140113. doi: 10.1371/journal.pone.0140113.", "ArticleIdList": ["10.1371/journal.pone.0140113", "PMC4607367", "26469405"]}, {"Citation": "Perez-Gutierrez R.M., Damian-Guzman M. Meliacinolin: A potent alpha-glucosidase and alpha-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice. Biol. Pharm. Bull. 2012;35:1516\u20131524. doi: 10.1248/bpb.b12-00246.", "ArticleIdList": ["10.1248/bpb.b12-00246", "22975503"]}, {"Citation": "World Health Organization . WHO Monographs on Selected Medicinal Plants. Volume 4 World Health Organization; Geneva, Switzerland: 2009."}, {"Citation": "Yuwai K.E., Rao K.S., Kaluwin C., Jones G.P., Rivett D.E. Chemical composition of Momordica charantia L. fruits. J. Agric. Food Chem. 1991;39:1762\u20131763. doi: 10.1021/jf00010a013.", "ArticleIdList": ["10.1021/jf00010a013"]}, {"Citation": "Ooi C.P., Yassin Z., Hamid T.-A. Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2012;15:CD007845. doi: 10.1002/14651858.CD007845.pub3.", "ArticleIdList": ["10.1002/14651858.CD007845.pub3", "22895968"]}, {"Citation": "Dans A.M.L., Villarruz M.V.C., Jimeno C.A., Javelosa M.A.U., Chua J., Bautista R., Velez G.G.B. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J. Clin. Epidemiol. 2007;60:554\u2013559. doi: 10.1016/j.jclinepi.2006.07.009.", "ArticleIdList": ["10.1016/j.jclinepi.2006.07.009", "17493509"]}, {"Citation": "John A.J., Cherian R., Subhash H.S., Cherian A.M. Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent\u2014A randomized controlled clinical trial. Indian J. Physiol. Pharmacol. 2003;47:363\u2013365.", "ArticleIdList": ["14723327"]}, {"Citation": "Fuangchan A., Sonthisombat P., Seubnukarn T., Chanouan R., Chotchaisuwat P., Sirigulsatien V., Ingkaninan K., Plianbangchang P., Haines S.T. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J. Ethnopharmacol. 2011;134:422\u2013428. doi: 10.1016/j.jep.2010.12.045.", "ArticleIdList": ["10.1016/j.jep.2010.12.045", "21211558"]}, {"Citation": "Grover J.K., Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 2004;93:123\u2013132. doi: 10.1016/j.jep.2004.03.035.", "ArticleIdList": ["10.1016/j.jep.2004.03.035", "15182917"]}, {"Citation": "Chuang C.-Y., Hsu C., Chao C.-Y., Wein Y.-S., Kuo Y.-H., Huang C. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.) J. Biomed. Sci. 2006;13:763\u2013772. doi: 10.1007/s11373-006-9109-3.", "ArticleIdList": ["10.1007/s11373-006-9109-3", "16955349"]}, {"Citation": "Huang H.-L., Hong Y.-W., Wong Y.-H., Chen Y.-N., Chyuan J.-H., Huang C.-J., Chao P.-M. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br. J. Nutr. 2008;99:230\u2013239. doi: 10.1017/S0007114507793947.", "ArticleIdList": ["10.1017/S0007114507793947", "17651527"]}, {"Citation": "Shih C.-C., Lin C.-H., Lin W.-L. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res. Clin. Pract. 2008;81:134\u2013143. doi: 10.1016/j.diabres.2008.04.023.", "ArticleIdList": ["10.1016/j.diabres.2008.04.023", "18550200"]}, {"Citation": "Chang C.-I., Tseng H.-I., Liao Y.-W., Yen C.-H., Chen T.-M., Lin C.-C., Cheng H.-L. In vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24. Food Chem. 2011;125:521\u2013528. doi: 10.1016/j.foodchem.2010.09.043.", "ArticleIdList": ["10.1016/j.foodchem.2010.09.043"]}, {"Citation": "Ma J., Whittaker P., Keller A.C., Mazzola E.P., Pawar R.S., White K.D., Callahan J.H., Kennelly E.J., Krynitsky A.J., Rader J.I. Cucurbitane-type triterpenoids from Momordica charantia. Planta Med. 2010;76:1758\u20131761. doi: 10.1055/s-0030-1249807.", "ArticleIdList": ["10.1055/s-0030-1249807", "20379957"]}, {"Citation": "Tan M.-J., Ye J.-M., Turner N., Hohnen-Behrens C., Ke C.-Q., Tang C.-P., Chen T., Weiss H.-C., Gesing E.-R., Rowland A., et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 2008;15:263\u2013273. doi: 10.1016/j.chembiol.2008.01.013.", "ArticleIdList": ["10.1016/j.chembiol.2008.01.013", "18355726"]}, {"Citation": "Cheng H.-L., Huang H.-K., Chang C.-I., Tsai C.-P., Chou C.-H. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase. J. Agric. Food Chem. 2008;56:6835\u20136843. doi: 10.1021/jf800801k.", "ArticleIdList": ["10.1021/jf800801k", "18656931"]}, {"Citation": "Harinantenaina L., Tanaka M., Takaoka S., Oda M., Mogami O., Uchida M., Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. 2006;54:1017\u20131021. doi: 10.1248/cpb.54.1017.", "ArticleIdList": ["10.1248/cpb.54.1017", "16819222"]}, {"Citation": "Cheng H.-L., Kuo C.-Y., Liao Y.-W., Lin C.-C. EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-alpha-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner. Eur. J. Pharmacol. 2012;689:241\u2013248. doi: 10.1016/j.ejphar.2012.05.033.", "ArticleIdList": ["10.1016/j.ejphar.2012.05.033", "22683870"]}, {"Citation": "Sasa M., Inoue I., Shinoda Y., Takahashi S., Seo M., Komoda T., Awata T., Katayama S. Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta. J. Atheroscler. Thromb. 2009;16:888\u2013892. doi: 10.5551/jat.2790.", "ArticleIdList": ["10.5551/jat.2790", "20032574"]}, {"Citation": "Efird J.T., Choi Y.M., Davies S.W., Mehra S., Anderson E.J., Katunga L.A. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int. J. Environ. Res. Public Health. 2014;11:2328\u20132345. doi: 10.3390/ijerph110202328.", "ArticleIdList": ["10.3390/ijerph110202328", "PMC3945602", "24566057"]}, {"Citation": "World Health Organization . WHO Monographs on Selected Medicinal Plants. Volume 2 World Health Organization; Geneva, Switzerland: 2002."}, {"Citation": "Pattanayak P., Behera P., Das D., Panda S.K. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn. Rev. 2010;4:95\u2013105. doi: 10.4103/0973-7847.65323.", "ArticleIdList": ["10.4103/0973-7847.65323", "PMC3249909", "22228948"]}, {"Citation": "Agrawal P., Rai V., Singh R.B. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. Int. J. Clin. Pharmacol. Ther. 1996;34:406\u2013409.", "ArticleIdList": ["8880292"]}, {"Citation": "Satapathy S., Das N., Bandyopadhyay D., Mahapatra S.C., Sahu D.S., Meda M. Effect of Tulsi (Ocimum sanctum Linn.) Supplementation on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects. Indian J. Clin. Biochem. 2017;32:357\u2013363. doi: 10.1007/s12291-016-0615-4.", "ArticleIdList": ["10.1007/s12291-016-0615-4", "PMC5539010", "28811698"]}, {"Citation": "Kapoor S. Ocimum sanctum: A therapeutic role in diabetes and the metabolic syndrome. Horm. Metab. Res. 2008;40:296. doi: 10.1055/s-2008-1058102.", "ArticleIdList": ["10.1055/s-2008-1058102", "18425717"]}, {"Citation": "Hussain E.H.M.A., Jamil K., Rao M. Hypoglycaemic, hypolipidemic and antioxidant properties of tulsi (Ocimum sanctum linn) on streptozotocin induced diabetes in rats. Indian J. Clin. Biochem. 2001;16:190\u2013194. doi: 10.1007/BF02864859.", "ArticleIdList": ["10.1007/BF02864859", "PMC3453628", "23105316"]}, {"Citation": "Reddy S.S., Karuna R., Baskar R., Saralakumari D. Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose-fed rats. Horm. Metab. Res. 2008;40:44\u201349. doi: 10.1055/s-2007-993218.", "ArticleIdList": ["10.1055/s-2007-993218", "18085503"]}, {"Citation": "Chattopadhyay R.R. Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats. Indian J. Exp. Biol. 1993;31:891\u2013893.", "ArticleIdList": ["8112763"]}, {"Citation": "Hannan J.M.A., Marenah L., Ali L., Rokeya B., Flatt P.R., Abdel-Wahab Y.H.A. Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic beta-cells. J. Endocrinol. 2006;189:127\u2013136. doi: 10.1677/joe.1.06615.", "ArticleIdList": ["10.1677/joe.1.06615", "16614387"]}, {"Citation": "Husain I., Chander R., Saxena J.K., Mahdi A.A., Mahdi F. Antidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats. Indian J. Clin. Biochem. 2015;30:72\u201377. doi: 10.1007/s12291-013-0404-2.", "ArticleIdList": ["10.1007/s12291-013-0404-2", "PMC4310851", "25646044"]}, {"Citation": "Suanarunsawat T., Anantasomboon G., Piewbang C. Anti-diabetic and anti-oxidative activity of fixed oil extracted from Ocimum sanctum L. leaves in diabetic rats. Exp. Ther. Med. 2016;11:832\u2013840. doi: 10.3892/etm.2016.2991.", "ArticleIdList": ["10.3892/etm.2016.2991", "PMC4774317", "26998000"]}, {"Citation": "Patil R., Patil R., Ahirwar B., Ahirwar D. Isolation and characterization of anti-diabetic component (bioactivity-guided fractionation) from Ocimum sanctum L. (Lamiaceae) aerial part. Asian Pac. J. Trop. Med. 2011;4:278\u2013282. doi: 10.1016/S1995-7645(11)60086-2.", "ArticleIdList": ["10.1016/S1995-7645(11)60086-2", "21771470"]}, {"Citation": "Mancuso C., Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem. Toxicol. 2017;107:362\u2013372. doi: 10.1016/j.fct.2017.07.019.", "ArticleIdList": ["10.1016/j.fct.2017.07.019", "PMC7116968", "28698154"]}, {"Citation": "Park H.J., Kim D.H., Park S.J., Kim J.M., Ryu J.H. Ginseng in Traditional Herbal Prescriptions. J. Ginseng Res. 2012;36:225\u2013241. doi: 10.5142/jgr.2012.36.3.225.", "ArticleIdList": ["10.5142/jgr.2012.36.3.225", "PMC3659587", "23717123"]}, {"Citation": "Xiang Y.-Z., Shang H.-C., Gao X.-M., Zhang B.-L. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother. Res. 2008;22:851\u2013858. doi: 10.1002/ptr.2384.", "ArticleIdList": ["10.1002/ptr.2384", "18567057"]}, {"Citation": "European Medicine Agency Community Herbal Monograph on Panax ginseng C.A. Meyer, Radix.  [(accessed on 9 October 2017)]; Available online:  http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2014/05/WC500167387.pdf."}, {"Citation": "Wang Y., Choi H.-K., Brinckmann J.A., Jiang X., Huang L. Chemical analysis of Panax quinquefolius (North American ginseng): A review. J. Chromatogr. A. 2015;1426:1\u201315. doi: 10.1016/j.chroma.2015.11.012.", "ArticleIdList": ["10.1016/j.chroma.2015.11.012", "26643719"]}, {"Citation": "Kim S., Shin B.-C., Lee M.S., Lee H., Ernst E. Red ginseng for type 2 diabetes mellitus: A systematic review of randomized controlled trials. Chin. J. Integr. Med. 2011;17:937\u2013944. doi: 10.1007/s11655-011-0937-2.", "ArticleIdList": ["10.1007/s11655-011-0937-2", "22139546"]}, {"Citation": "Shergis J.L., Zhang A.L., Zhou W., Xue C.C. Panax ginseng in randomised controlled trials: A systematic review. Phytother. Res. 2013;27:949\u2013965. doi: 10.1002/ptr.4832.", "ArticleIdList": ["10.1002/ptr.4832", "22969004"]}, {"Citation": "Shishtar E., Sievenpiper J.L., Djedovic V., Cozma A.I., Ha V., Jayalath V.H., Jenkins D.J.A., Meija S.B., de Souza R.J., Jovanovski E., et al. The effect of ginseng (the genus panax) on glycemic control: A systematic review and meta-analysis of randomized controlled clinical trials. PLoS ONE. 2014;9:e107391. doi: 10.1371/journal.pone.0107391.", "ArticleIdList": ["10.1371/journal.pone.0107391", "PMC4180277", "25265315"]}, {"Citation": "Gui Q.-F., Xu Z.-R., Xu K.-Y., Yang Y.-M. The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis. Medicine. 2016;95:e2584. doi: 10.1097/MD.0000000000002584.", "ArticleIdList": ["10.1097/MD.0000000000002584", "PMC4753873", "26871778"]}, {"Citation": "Liu C., Zhang M., Hu M.-Y., Guo H.-F., Li J., Yu Y.-L., Jin S., Wang X.-T., Liu L., Liu X.-D. Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides. J. Endocrinol. 2013;217:185\u2013196. doi: 10.1530/JOE-12-0502.", "ArticleIdList": ["10.1530/JOE-12-0502", "23444389"]}, {"Citation": "Niu J., Pi Z., Yue H., Wang Y., Yu Q., Liu S. Effect of ginseng polysaccharide on the urinary excretion of type 2 diabetic rats studied by liquid chromatography-mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012;907:7\u201312. doi: 10.1016/j.jchromb.2012.08.012.", "ArticleIdList": ["10.1016/j.jchromb.2012.08.012", "22998979"]}, {"Citation": "Deng J., Liu Y., Duan Z., Zhu C., Hui J., Mi Y., Ma P., Ma X., Fan D., Yang H. Protopanaxadiol and Protopanaxatriol-Type Saponins Ameliorate Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus in High-Fat Diet/Streptozocin-Induced Mice. Front. Pharmacol. 2017;8:506. doi: 10.3389/fphar.2017.00506.", "ArticleIdList": ["10.3389/fphar.2017.00506", "PMC5539091", "28824430"]}, {"Citation": "Jiang S., Ren D., Li J., Yuan G., Li H., Xu G., Han X., Du P., An L. Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus. Fitoterapia. 2014;95:58\u201364. doi: 10.1016/j.fitote.2014.02.017.", "ArticleIdList": ["10.1016/j.fitote.2014.02.017", "24613802"]}, {"Citation": "Yang N., Chen P., Tao Z., Zhou N., Gong X., Xu Z., Zhang M., Zhang D., Chen B., Tao Z., et al. Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice. Acta Biochim. Biophys. Sin. 2012;44:999\u20131005. doi: 10.1093/abbs/gms092.", "ArticleIdList": ["10.1093/abbs/gms092", "23111241"]}, {"Citation": "Kang K.S., Yamabe N., Kim H.Y., Park J.H., Yokozawa T. Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. Eur. J. Pharmacol. 2008;591:266\u2013272. doi: 10.1016/j.ejphar.2008.06.077.", "ArticleIdList": ["10.1016/j.ejphar.2008.06.077", "18611400"]}, {"Citation": "Niu J., Pi Z.-F., Yue H., Yang H., Wang Y., Yu Q., Liu S.-Y. Effect of 20(S)-ginsenoside Rg3 on streptozotocin-induced experimental type 2 diabetic rats: A urinary metabonomics study by rapid-resolution liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2012;26:2683\u20132689. doi: 10.1002/rcm.6392.", "ArticleIdList": ["10.1002/rcm.6392", "23124658"]}, {"Citation": "Lai D.-M., Tu Y.-K., Liu I.-M., Chen P.-F., Cheng J.-T. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2006;72:9\u201313. doi: 10.1055/s-2005-916177.", "ArticleIdList": ["10.1055/s-2005-916177", "16450289"]}, {"Citation": "Kim H.Y., Kang K.S., Yamabe N., Yokozawa T. Comparison of the effects of Korean ginseng and heat-processed Korean ginseng on diabetic oxidative stress. Am. J. Chin. Med. 2008;36:989\u20131004. doi: 10.1142/S0192415X08006417.", "ArticleIdList": ["10.1142/S0192415X08006417", "19051363"]}, {"Citation": "Seo Y.-S., Shon M.-Y., Kong R., Kang O.-H., Zhou T., Kim D.-Y., Kwon D.-Y. Black ginseng extract exerts anti-hyperglycemic effect via modulation of glucose metabolism in liver and muscle. J. Ethnopharmacol. 2016;190:231\u2013240. doi: 10.1016/j.jep.2016.05.060.", "ArticleIdList": ["10.1016/j.jep.2016.05.060", "27260409"]}, {"Citation": "Kim J.H., Pan J.H., Cho H.T., Kim Y.J. Black Ginseng Extract Counteracts Streptozotocin-Induced Diabetes in Mice. PLoS ONE. 2016;11:e0146843. doi: 10.1371/journal.pone.0146843.", "ArticleIdList": ["10.1371/journal.pone.0146843", "PMC4709037", "26751692"]}, {"Citation": "Kim C.-S., Jo K., Pyo M.-K., Kim J.S., Kim J. Pectin lyase-modified red ginseng extract exhibits potent anti-glycation effects in vitro and in vivo. J. Exerc. Nutr. Biochem. 2017;21:56\u201362. doi: 10.20463/jenb.2017.0011.", "ArticleIdList": ["10.20463/jenb.2017.0011", "PMC5545198", "28715887"]}, {"Citation": "Murthy H.N., Dandin V.S., Lee E.J., Paek K.Y. Efficacy of ginseng adventitious root extract on hyperglycemia in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2014;153:917\u2013921. doi: 10.1016/j.jep.2014.03.062.", "ArticleIdList": ["10.1016/j.jep.2014.03.062", "24709314"]}, {"Citation": "Liu C., Ma R., Wang L., Zhu R., Liu H., Guo Y., Zhao B., Zhao S., Tang J., Li Y., et al. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J. Ethnopharmacol. 2017;198:351\u2013362. doi: 10.1016/j.jep.2017.01.021.", "ArticleIdList": ["10.1016/j.jep.2017.01.021", "28111216"]}, {"Citation": "Matsumoto Y., Sekimizu K. A hyperglycemic silkworm model for evaluating hypoglycemic activity of Rehmanniae Radix, an herbal medicine. Drug Discov. Ther. 2016;10:14\u201318. doi: 10.5582/ddt.2016.01016.", "ArticleIdList": ["10.5582/ddt.2016.01016", "26902904"]}, {"Citation": "Ursini F., Maiorino M., Forman H.J. Redox homeostasis: The Golden Mean of healthy living. Redox Biol. 2016;8:205\u2013215. doi: 10.1016/j.redox.2016.01.010.", "ArticleIdList": ["10.1016/j.redox.2016.01.010", "PMC4732014", "26820564"]}, {"Citation": "Baek G.-H., Jang Y.-S., Jeong S.-I., Cha J., Joo M., Shin S.-W., Ha K.-T., Jeong H.-S. Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation. 2012;35:1232\u20131241. doi: 10.1007/s10753-012-9433-x.", "ArticleIdList": ["10.1007/s10753-012-9433-x", "22327862"]}, {"Citation": "Zhang R., Zhou J., Jia Z., Zhang Y., Gu G. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J. Ethnopharmacol. 2004;90:39\u201343. doi: 10.1016/j.jep.2003.09.018.", "ArticleIdList": ["10.1016/j.jep.2003.09.018", "14698506"]}, {"Citation": "Zhou J., Xu G., Yan J., Li K., Bai Z., Cheng W., Huang K. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice. J. Ethnopharmacol. 2015;164:229\u2013238. doi: 10.1016/j.jep.2015.02.026.", "ArticleIdList": ["10.1016/j.jep.2015.02.026", "25698243"]}, {"Citation": "Zhang R.X., Jia Z.P., Kong L.Y., Ma H.P., Ren J., Li M.X., Ge X. Stachyose extract from Rehmannia glutinosa Libosch. to lower plasma glucose in normal and diabetic rats by oral administration. Pharmazie. 2004;59:552\u2013556.", "ArticleIdList": ["15296094"]}, {"Citation": "Choi H.-J., Jang H.-J., Chung T.-W., Jeong S.-I., Cha J., Choi J.-Y., Han C.W., Jang Y.-S., Joo M., Jeong H.-S., et al. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells. Fitoterapia. 2013;86:19\u201328. doi: 10.1016/j.fitote.2013.01.014.", "ArticleIdList": ["10.1016/j.fitote.2013.01.014", "23376161"]}, {"Citation": "Zhu H., Wang Y., Liu Z., Wang J., Wan D., Feng S., Yang X., Wang T. Antidiabetic and antioxidant effects of catalpol extracted from Rehmannia glutinosa (Di Huang) on rat diabetes induced by streptozotocin and high-fat, high-sugar feed. Chin. Med. 2016;11:25. doi: 10.1186/s13020-016-0096-7.", "ArticleIdList": ["10.1186/s13020-016-0096-7", "PMC4864906", "27175212"]}, {"Citation": "Yang S., Deng H., Zhang Q., Xie J., Zeng H., Jin X., Ling Z., Shan Q., Liu M., Ma Y., et al. Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling. PLoS ONE. 2016;11:e0151857. doi: 10.1371/journal.pone.0151857.", "ArticleIdList": ["10.1371/journal.pone.0151857", "PMC4795681", "26986757"]}, {"Citation": "Zhou J., Xu G., Ma S., Li F., Yuan M., Xu H., Huang K. Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-kappaB pathways. Biochem. Biophys. Res. Commun. 2015;467:853\u2013858. doi: 10.1016/j.bbrc.2015.10.054.", "ArticleIdList": ["10.1016/j.bbrc.2015.10.054", "26474703"]}, {"Citation": "Dong Z., Chen C.X. Effect of catalpol on diabetic nephropathy in rats. Phytomedicine. 2013;20:1023\u20131029. doi: 10.1016/j.phymed.2013.04.007.", "ArticleIdList": ["10.1016/j.phymed.2013.04.007", "23746755"]}, {"Citation": "Bahmani M., Shirzad H., Mirhosseini M., Mesripour A., Rafieian-Kopaei M. A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L.) J. Evid.-Based. Complement. Altern. Med. 2016;21:53\u201362. doi: 10.1177/2156587215583405.", "ArticleIdList": ["10.1177/2156587215583405", "25922446"]}, {"Citation": "Neelakantan N., Narayanan M., de Souza R.J., van Dam R.M. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: A meta-analysis of clinical trials. Nutr. J. 2014;13:7. doi: 10.1186/1475-2891-13-7.", "ArticleIdList": ["10.1186/1475-2891-13-7", "PMC3901758", "24438170"]}, {"Citation": "Suksomboon N., Poolsup N., Boonkaew S., Suthisisang C.C. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J. Ethnopharmacol. 2011;137:1328\u20131333. doi: 10.1016/j.jep.2011.07.059.", "ArticleIdList": ["10.1016/j.jep.2011.07.059", "21843614"]}, {"Citation": "Shojaii A., Dabaghian F.H., Goushegir A., Fard M.A. Antidiabetic plants of Iran. Acta Med. Iran. 2011;49:637\u2013642.", "ArticleIdList": ["22071637"]}, {"Citation": "Nahas R., Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can. Fam. Physician. 2009;55:591\u2013596.", "ArticleIdList": ["PMC2694078", "19509199"]}, {"Citation": "Raju J., Gupta D., Rao A.R., Yadava P.K., Baquer N.Z. Trigonellafoenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol. Cell. Biochem. 2001;224:45\u201351. doi: 10.1023/A:1011974630828.", "ArticleIdList": ["10.1023/A:1011974630828", "11693199"]}, {"Citation": "Ravikumar P., Anuradha C.V. Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother. Res. 1999;13:197\u2013201. doi: 10.1002/(SICI)1099-1573(199905)13:3<197::AID-PTR413>3.0.CO;2-L.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199905)13:3<197::AID-PTR413>3.0.CO;2-L", "10353156"]}, {"Citation": "Vijayakumar M.V., Singh S., Chhipa R.R., Bhat M.K. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br. J. Pharmacol. 2005;146:41\u201348. doi: 10.1038/sj.bjp.0706312.", "ArticleIdList": ["10.1038/sj.bjp.0706312", "PMC1576255", "15980869"]}, {"Citation": "Koupy D., Kotolova H., Ruda Kucerova J. Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II. Fenugreek (Trigonella foenum-graecum) Ceska Slov. Farm. 2015;64:67\u201371.", "ArticleIdList": ["26400229"]}, {"Citation": "Zhou J., Chan L., Zhou S. Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease. Curr. Med. Chem. 2012;19:3523\u20133531.", "ArticleIdList": ["22680628"]}, {"Citation": "Kalailingam P., Kannaian B., Tamilmani E., Kaliaperumal R. Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats. Phytomedicine. 2014;21:1154\u20131161. doi: 10.1016/j.phymed.2014.04.005.", "ArticleIdList": ["10.1016/j.phymed.2014.04.005", "24889525"]}, {"Citation": "Uemura T., Hirai S., Mizoguchi N., Goto T., Lee J.-Y., Taketani K., Nakano Y., Shono J., Hoshino S., Tsuge N., et al. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol. Nutr. Food Res. 2010;54:1596\u20131608. doi: 10.1002/mnfr.200900609.", "ArticleIdList": ["10.1002/mnfr.200900609", "20540147"]}, {"Citation": "Son I.S., Kim J.H., Sohn H.Y., Son K.H., Kim J.-S., Kwon C.-S. Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci. Biotechnol. Biochem. 2007;71:3063\u20133071. doi: 10.1271/bbb.70472.", "ArticleIdList": ["10.1271/bbb.70472", "18071250"]}, {"Citation": "Zafar M.I., Gao F. 4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus. BioDrugs. 2016;30:255\u2013262. doi: 10.1007/s40259-016-0177-2.", "ArticleIdList": ["10.1007/s40259-016-0177-2", "27151154"]}, {"Citation": "Jette L., Harvey L., Eugeni K., Levens N. 4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndrome. Curr. Opin. Investig. Drugs. 2009;10:353\u2013358.", "ArticleIdList": ["19337956"]}, {"Citation": "Broca C., Manteghetti M., Gross R., Baissac Y., Jacob M., Petit P., Sauvaire Y., Ribes G. 4-Hydroxyisoleucine: Effects of synthetic and natural analogues on insulin secretion. Eur. J. Pharmacol. 2000;390:339\u2013345. doi: 10.1016/S0014-2999(00)00030-3.", "ArticleIdList": ["10.1016/S0014-2999(00)00030-3", "10708743"]}, {"Citation": "Sauvaire Y., Petit P., Broca C., Manteghetti M., Baissac Y., Fernandez-Alvarez J., Gross R., Roye M., Leconte A., Gomis R., et al. 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes. 1998;47:206\u2013210. doi: 10.2337/diab.47.2.206.", "ArticleIdList": ["10.2337/diab.47.2.206", "9519714"]}, {"Citation": "Hannan J.M.A., Ali L., Rokeya B., Khaleque J., Akhter M., Flatt P.R., Abdel-Wahab Y.H.A. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br. J. Nutr. 2007;97:514\u2013521. doi: 10.1017/S0007114507657869.", "ArticleIdList": ["10.1017/S0007114507657869", "17313713"]}, {"Citation": "Srichamroen A., Field C.J., Thomson A.B.R., Basu T.K. The Modifying Effects of Galactomannan from Canadian-Grown Fenugreek (Trigonella foenum-graecum L.) on the Glycemic and Lipidemic Status in Rats. J. Clin. Biochem. Nutr. 2008;43:167\u2013174. doi: 10.3164/jcbn.2008060.", "ArticleIdList": ["10.3164/jcbn.2008060", "PMC2581758", "19015751"]}, {"Citation": "Hannan J.M.A., Rokeya B., Faruque O., Nahar N., Mosihuzzaman M., Azad Khan A.K., Ali L. Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of Type 2 diabetic model rats. J. Ethnopharmacol. 2003;88:73\u201377. doi: 10.1016/S0378-8741(03)00190-9.", "ArticleIdList": ["10.1016/S0378-8741(03)00190-9", "12902054"]}, {"Citation": "Sathasivampillai S.V., Rajamanoharan P.R.S., Munday M., Heinrich M. Plants used to treat diabetes in Sri Lankan Siddha Medicine\u2014An ethnopharmacological review of historical and modern sources. J. Ethnopharmacol. 2017;198:531\u2013599. doi: 10.1016/j.jep.2016.07.053.", "ArticleIdList": ["10.1016/j.jep.2016.07.053", "27448453"]}, {"Citation": "Afifi-Yazar F.U., Kasabri V., Abu-Dahab R. Medicinal plants from Jordan in the treatment of diabetes: Traditional uses vs. in vitro and in vivo evaluations\u2014Part 2. Planta Med. 2011;77:1210\u20131220. doi: 10.1055/s-0031-1279983.", "ArticleIdList": ["10.1055/s-0031-1279983", "21674438"]}, {"Citation": "Ezuruike U.F., Prieto J.M. The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. J. Ethnopharmacol. 2014;155:857\u2013924. doi: 10.1016/j.jep.2014.05.055.", "ArticleIdList": ["10.1016/j.jep.2014.05.055", "24929108"]}, {"Citation": "Yin J., Zhang H., Ye J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug Targets. 2008;8:99\u2013111. doi: 10.2174/187153008784534330.", "ArticleIdList": ["10.2174/187153008784534330", "PMC2467395", "18537696"]}, {"Citation": "Patel D.K., Prasad S.K., Kumar R., Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2012;2:320\u2013330. doi: 10.1016/S2221-1691(12)60032-X.", "ArticleIdList": ["10.1016/S2221-1691(12)60032-X", "PMC3609288", "23569923"]}, {"Citation": "Farzaei F., Morovati M.R., Farjadmand F., Farzaei M.H. A Mechanistic Review on Medicinal Plants Used for Diabetes Mellitus in Traditional Persian Medicine. J. Evid.-Based Complement. Altern. Med. 2017 doi: 10.1177/2156587216686461. in press.", "ArticleIdList": ["10.1177/2156587216686461", "PMC5871259", "29228789"]}, {"Citation": "Pubmed.  [(accessed on 29 December 2017)]; Available online:  http://www.ncbi.nlm.nih.gov/pubmed."}, {"Citation": "Vasant More S., Kim I.-S., Choi D.-K. Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy. Molecules. 2017;22:76. doi: 10.3390/molecules22010076.", "ArticleIdList": ["10.3390/molecules22010076", "PMC6155640", "28054988"]}, {"Citation": "NIH ClinicalTrials.gov.  [(accessed on 22 November 2017)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT02370121."}, {"Citation": "Pothuraju R., Sharma R.K., Chagalamarri J., Jangra S., Kumar Kavadi P. A systematic review of Gymnema sylvestre in obesity and diabetes management. J. Sci. Food Agric. 2014;94:834\u2013840. doi: 10.1002/jsfa.6458.", "ArticleIdList": ["10.1002/jsfa.6458", "24166097"]}, {"Citation": "Tiwari P., Mishra B.N., Sangwan N.S. Phytochemical and Pharmacological Properties of Gymnema sylvestre: An Important Medicinal Plant. Biomed. Res. Int. 2014;2014:830285. doi: 10.1155/2014/830285.", "ArticleIdList": ["10.1155/2014/830285", "PMC3912882", "24511547"]}, {"Citation": "Daisy P., Eliza J., Mohamed Farook K.A.M. A novel dihydroxy gymnemic triacetate isolated from Gymnema sylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats. J. Ethnopharmacol. 2009;126:339\u2013344. doi: 10.1016/j.jep.2009.08.018.", "ArticleIdList": ["10.1016/j.jep.2009.08.018", "19703537"]}, {"Citation": "Al-Romaiyan A., Liu B., Asare-Anane H., Maity C.R., Chatterjee S.K., Koley N., Biswas T., Chatterji A.K., Huang G.-C., Amiel S.A., et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother. Res. 2010;24:1370\u20131376. doi: 10.1002/ptr.3125.", "ArticleIdList": ["10.1002/ptr.3125", "20812281"]}, {"Citation": "Kumar S.N., Mani U.V., Mani I. An open label study on the supplementation of Gymnema sylvestre in type 2 diabetics. J. Diet. Suppl. 2010;7:273\u2013282. doi: 10.3109/19390211.2010.505901.", "ArticleIdList": ["10.3109/19390211.2010.505901", "22432517"]}, {"Citation": "Mart\u00ednez-Abundis E., M\u00e9ndez-del Villar M., P\u00e9rez-Rubio K.G., Zu\u00f1iga L.Y., Cortez-Navarrete M., Ram\u00edrez-Rodriguez A., Gonz\u00e1lez-Ortiz M. Novel nutraceutic therapies for the treatment of metabolic syndrome. World J. Diabetes. 2016;7:142\u2013152. doi: 10.4239/wjd.v7.i7.142.", "ArticleIdList": ["10.4239/wjd.v7.i7.142", "PMC4824685", "27076875"]}, {"Citation": "Demmers A., Korthout H., van Etten-Jamaludin F.S., Kortekaas F., Maaskant J.M. Effects of medicinal food plants on impaired glucose tolerance: A systematic review of randomized controlled trials. Diabetes Res. Clin. Pract. 2017;131:91\u2013106. doi: 10.1016/j.diabres.2017.05.024.", "ArticleIdList": ["10.1016/j.diabres.2017.05.024", "28750220"]}, {"Citation": "Gryn-Rynko A., Bazylak G., Olszewska-Slonina D. New potential phytotherapeutics obtained from white mulberry (Morus alba L.) leaves. Biomed. Pharmacother. 2016;84:628\u2013636. doi: 10.1016/j.biopha.2016.09.081.", "ArticleIdList": ["10.1016/j.biopha.2016.09.081", "27694008"]}, {"Citation": "Kim J.Y., Ok H.M., Kim J., Park S.W., Kwon S.W., Kwon O. Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: A randomized, double-blind placebo-controlled trial. J. Med. Food. 2015;18:306\u2013313. doi: 10.1089/jmf.2014.3160.", "ArticleIdList": ["10.1089/jmf.2014.3160", "25343729"]}, {"Citation": "Jovanovski E., Li D., Thanh Ho H.V., Djedovic V., de Ruiz Marques A.C., Shishtar E., Mejia S.B., Sievenpiper J.L., de Souza R.J., Duvnjak L., et al. The effect of alpha-linolenic acid on glycemic control in individuals with type 2 diabetes: A systematic review and meta-analysis of randomized controlled clinical trials. Medicine. 2017;96:e6531. doi: 10.1097/MD.0000000000006531.", "ArticleIdList": ["10.1097/MD.0000000000006531", "PMC5457843", "28538363"]}, {"Citation": "Singh K.K., Mridula D., Rehal J., Barnwal P. Flaxseed: A potential source of food, feed and fiber. Crit. Rev. Food Sci. Nutr. 2011;51:210\u2013222. doi: 10.1080/10408390903537241.", "ArticleIdList": ["10.1080/10408390903537241", "21390942"]}, {"Citation": "Akrami A., Nikaein F., Babajafari S., Faghih S., Yarmohammadi H. Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome. J. Clin. Lipidol. 2017 doi: 10.1016/j.jacl.2017.11.004. in press.", "ArticleIdList": ["10.1016/j.jacl.2017.11.004", "29229363"]}, {"Citation": "Hashemzadeh A.A., Nasoohi N., Raygan F., Aghadavod E., Akbari E., Taghizadeh M., Memarzadeh M.R., Asemi Z. Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-gamma, LP(a), IL-1 and TNF-alpha in Type 2 Diabetic Patients with Coronary Heart Disease. Lipids. 2017;52:907\u2013915. doi: 10.1007/s11745-017-4295-5.", "ArticleIdList": ["10.1007/s11745-017-4295-5", "28916975"]}, {"Citation": "Mani U.V., Mani I., Biswas M., Kumar S.N. An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus. J. Diet. Suppl. 2011;8:257\u2013265. doi: 10.3109/19390211.2011.593615.", "ArticleIdList": ["10.3109/19390211.2011.593615", "22432725"]}, {"Citation": "Thakur G., Mitra A., Pal K., Rousseau D. Effect of flaxseed gum on reduction of blood glucose and cholesterol in type 2 diabetic patients. Int. J. Food Sci. Nutr. 2009;60:126\u2013136. doi: 10.1080/09637480903022735.", "ArticleIdList": ["10.1080/09637480903022735", "19548163"]}, {"Citation": "Hidalgo J., Flores C., Hidalgo M.A., Perez M., Yanez A., Quinones L., Caceres D.D., Burgos R.A. Delphinol(R) standardized maqui berry extract reduces postprandial blood glucose increase in individuals with impaired glucose regulation by novel mechanism of sodium glucose cotransporter inhibition. Panminerva Med. 2014;56:1\u20137.", "ArticleIdList": ["24861886"]}, {"Citation": "Alvarado J., Schoenlau F., Leschot A., Salgad A.M., Vigil Portales P. Delphinol(R) standardized maqui berry extract significantly lowers blood glucose and improves blood lipid profile in prediabetic individuals in three-month clinical trial. Panminerva Med. 2016;58:1\u20136.", "ArticleIdList": ["27820958"]}, {"Citation": "Paula P.C., Oliveira J.T.A., Sousa D.O.B., Alves B.G.T., Carvalho A.F.U., Franco O.L., Vasconcelos I.M. Insulin-like plant proteins as potential innovative drugs to treat diabetes\u2014The Moringa oleifera case study. New Biotechnol. 2017;39:99\u2013109. doi: 10.1016/j.nbt.2016.10.005.", "ArticleIdList": ["10.1016/j.nbt.2016.10.005", "27737801"]}, {"Citation": "Paula P.C., Sousa D.O.B., Oliveira J.T.A., Carvalho A.F.U., Alves B.G.T., Pereira M.L., Farias D.F., Viana M.P., Santos F.A., Morais T.C., et al. A Protein Isolate from Moringa oleifera Leaves Has Hypoglycemic and Antioxidant Effects in Alloxan-Induced Diabetic Mice. Molecules. 2017;22:271. doi: 10.3390/molecules22020271.", "ArticleIdList": ["10.3390/molecules22020271", "PMC6155657", "28208654"]}, {"Citation": "Omodanisi E.I., Aboua Y.G., Oguntibeju O.O. Assessment of the Anti-Hyperglycaemic, Anti-Inflammatory and Antioxidant Activities of the Methanol Extract of Moringa Oleifera in Diabetes-Induced Nephrotoxic Male Wistar Rats. Molecules. 2017;22:439. doi: 10.3390/molecules22040439.", "ArticleIdList": ["10.3390/molecules22040439", "PMC6153931", "28333074"]}, {"Citation": "Anthanont P., Lumlerdkij N., Akarasereenont P., Vannasaeng S., Sriwijitkamol A. Moringa Oleifera Leaf Increases Insulin Secretion after Single Dose Administration: A Preliminary Study in Healthy Subjects. J. Med. Assoc. Thail. 2016;99:308\u2013313.", "ArticleIdList": ["27276742"]}, {"Citation": "Akash M.S.H., Rehman K., Tariq M., Chen S. Zingiber officinale and Type 2 Diabetes Mellitus: Evidence from Experimental Studies. Crit. Rev. Eukaryot. Gene Expr. 2015;25:91\u2013112. doi: 10.1615/CritRevEukaryotGeneExpr.2015013358.", "ArticleIdList": ["10.1615/CritRevEukaryotGeneExpr.2015013358", "26080605"]}, {"Citation": "Shidfar F., Rajab A., Rahideh T., Khandouzi N., Hosseini S., Shidfar S. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J. Complement. Integr. Med. 2015;12:165\u2013170. doi: 10.1515/jcim-2014-0021.", "ArticleIdList": ["10.1515/jcim-2014-0021", "25719344"]}, {"Citation": "Nerurkar P.V., Hwang P.W., Saksa E. Anti-Diabetic Potential of Noni: The Yin and the Yang. Molecules. 2015;20:17684\u201317719. doi: 10.3390/molecules201017684.", "ArticleIdList": ["10.3390/molecules201017684", "PMC6331903", "26404212"]}, {"Citation": "Van Dieren S., Uiterwaal C.S.P.M., van der Schouw Y.T., van der A D.L., Boer J.M.A., Spijkerman A., Grobbee D.E., Beulens J.W.J. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009;52:2561\u20132569. doi: 10.1007/s00125-009-1516-3.", "ArticleIdList": ["10.1007/s00125-009-1516-3", "19727658"]}, {"Citation": "Akash M.S.H., Rehman K., Chen S. Effects of coffee on type 2 diabetes mellitus. Nutrition. 2014;30:755\u2013763. doi: 10.1016/j.nut.2013.11.020.", "ArticleIdList": ["10.1016/j.nut.2013.11.020", "24984989"]}, {"Citation": "Jokura H., Watanabe I., Umeda M., Hase T., Shimotoyodome A. Coffee polyphenol consumption improves postprandial hyperglycemia associated with impaired vascular endothelial function in healthy male adults. Nutr. Res. 2015;35:873\u2013881. doi: 10.1016/j.nutres.2015.07.005.", "ArticleIdList": ["10.1016/j.nutres.2015.07.005", "26337017"]}, {"Citation": "Mahmoud F., Haines D., Al-Ozairi E., Dashti A. Effect of Black Tea Consumption on Intracellular Cytokines, Regulatory T Cells and Metabolic Biomarkers in Type 2 Diabetes Patients. Phytother. Res. 2016;30:454\u2013462. doi: 10.1002/ptr.5548.", "ArticleIdList": ["10.1002/ptr.5548", "26692322"]}, {"Citation": "Park J.-H., Bae J.-H., Im S.-S., Song D.-K. Green tea and type 2 diabetes. Integr. Med. Res. 2014;3:4\u201310. doi: 10.1016/j.imr.2013.12.002.", "ArticleIdList": ["10.1016/j.imr.2013.12.002", "PMC5481694", "28664072"]}, {"Citation": "Archer A.W. Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography. J. Chromatogr. A. 1988;447:272\u2013276. doi: 10.1016/0021-9673(88)90035-0.", "ArticleIdList": ["10.1016/0021-9673(88)90035-0"]}, {"Citation": "Ranasinghe P., Pigera S., Premakumara G.A.S., Galappaththy P., Constantine G.R., Katulanda P. Medicinal properties of \u201ctrue\u201d cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complement. Altern. Med. 2013;13:275. doi: 10.1186/1472-6882-13-275.", "ArticleIdList": ["10.1186/1472-6882-13-275", "PMC3854496", "24148965"]}, {"Citation": "Costello R.B., Dwyer J.T., Saldanha L., Bailey R.L., Merkel J., Wambogo E. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J. Acad. Nutr. Diet. 2016;116:1794\u20131802. doi: 10.1016/j.jand.2016.07.015.", "ArticleIdList": ["10.1016/j.jand.2016.07.015", "PMC5085873", "27618575"]}, {"Citation": "Allen R.W., Schwartzman E., Baker W.L., Coleman C.I., Phung O.J. Cinnamon use in type 2 diabetes: An updated systematic review and meta-analysis. Ann. Fam. Med. 2013;11:452\u2013459. doi: 10.1370/afm.1517.", "ArticleIdList": ["10.1370/afm.1517", "PMC3767714", "24019277"]}, {"Citation": "Akilen R., Tsiami A., Devendra D., Robinson N. Cinnamon in glycaemic control: Systematic review and meta analysis. Clin. Nutr. 2012;31:609\u2013615. doi: 10.1016/j.clnu.2012.04.003.", "ArticleIdList": ["10.1016/j.clnu.2012.04.003", "22579946"]}, {"Citation": "Bandara T., Uluwaduge I., Jansz E.R. Bioactivity of cinnamon with special emphasis on diabetes mellitus: A review. Int. J. Food Sci. Nutr. 2012;63:380\u2013386. doi: 10.3109/09637486.2011.627849.", "ArticleIdList": ["10.3109/09637486.2011.627849", "22007625"]}, {"Citation": "Leach M.J., Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst. Rev. 2012;12:CD007170.", "ArticleIdList": ["PMC6486047", "22972104"]}, {"Citation": "Ranasinghe P., Jayawardana R., Galappaththy P., Constantine G.R., de Vas Gunawardana N., Katulanda P. Efficacy and safety of \u201ctrue\u201d cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: A systematic review and meta-analysis. Diabet. Med. 2012;29:1480\u20131492. doi: 10.1111/j.1464-5491.2012.03718.x.", "ArticleIdList": ["10.1111/j.1464-5491.2012.03718.x", "22671971"]}, {"Citation": "Qin B., Dawson H.D., Schoene N.W., Polansky M.M., Anderson R.A. Cinnamon polyphenols regulate multiple metabolic pathways involved in insulin signaling and intestinal lipoprotein metabolism of small intestinal enterocytes. Nutrition. 2012;28:1172\u20131179. doi: 10.1016/j.nut.2012.03.020.", "ArticleIdList": ["10.1016/j.nut.2012.03.020", "22858201"]}, {"Citation": "Adisakwattana S., Lerdsuwankij O., Poputtachai U., Minipun A., Suparpprom C. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal alpha-glucosidase and pancreatic alpha-amylase. Plant Foods Hum. Nutr. 2011;66:143\u2013148. doi: 10.1007/s11130-011-0226-4.", "ArticleIdList": ["10.1007/s11130-011-0226-4", "21538147"]}, {"Citation": "Couturier K., Batandier C., Awada M., Hininger-Favier I., Canini F., Anderson R.A., Leverve X., Roussel A.M. Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Arch. Biochem. Biophys. 2010;501:158\u2013161. doi: 10.1016/j.abb.2010.05.032.", "ArticleIdList": ["10.1016/j.abb.2010.05.032", "20515642"]}, {"Citation": "Anand P., Murali K.Y., Tandon V., Murthy P.S., Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem. Biol. Interact. 2010;186:72\u201381. doi: 10.1016/j.cbi.2010.03.044.", "ArticleIdList": ["10.1016/j.cbi.2010.03.044", "20363216"]}, {"Citation": "Ping H., Zhang G., Ren G. Antidiabetic effects of cinnamon oil in diabetic KK-Ay mice. Food Chem. Toxicol. 2010;48:2344\u20132349. doi: 10.1016/j.fct.2010.05.069.", "ArticleIdList": ["10.1016/j.fct.2010.05.069", "20561948"]}, {"Citation": "Subash Babu P., Prabuseenivasan S., Ignacimuthu S. Cinnamaldehyde\u2014A potential antidiabetic agent. Phytomedicine. 2007;14:15\u201322. doi: 10.1016/j.phymed.2006.11.005.", "ArticleIdList": ["10.1016/j.phymed.2006.11.005", "17140783"]}, {"Citation": "Kim S.H., Hyun S.H., Choung S.Y. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J. Ethnopharmacol. 2006;104:119\u2013123. doi: 10.1016/j.jep.2005.08.059.", "ArticleIdList": ["10.1016/j.jep.2005.08.059", "16213119"]}, {"Citation": "Roffey B., Atwal A., Kubow S. Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3T3-L1 adipose cells. Mol. Nutr. Food Res. 2006;50:739\u2013745. doi: 10.1002/mnfr.200500253.", "ArticleIdList": ["10.1002/mnfr.200500253", "16835867"]}, {"Citation": "Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm. Metab. Res. 2004;36:119\u2013125.", "ArticleIdList": ["15002064"]}, {"Citation": "Cao H., Polansky M.M., Anderson R.A. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch. Biochem. Biophys. 2007;459:214\u2013222. doi: 10.1016/j.abb.2006.12.034.", "ArticleIdList": ["10.1016/j.abb.2006.12.034", "17316549"]}, {"Citation": "Ulbricht C., Seamon E., Windsor R.C., Armbruester N., Bryan J.K., Costa D., Giese N., Gruenwald J., Iovin R., Isaac R., et al. An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2011;8:378\u2013454. doi: 10.3109/19390211.2011.627783.", "ArticleIdList": ["10.3109/19390211.2011.627783", "22432776"]}, {"Citation": "Corns C.M. Herbal remedies and clinical biochemistry. Ann. Clin. Biochem. 2003;40:489\u2013507. doi: 10.1258/000456303322326407.", "ArticleIdList": ["10.1258/000456303322326407", "14503986"]}, {"Citation": "Sproll C., Ruge W., Andlauer C., Godelmann R., Lachenmeier D.W. HPLC analysis and safety assessment of coumarin in foods. Food Chem. 2008;109:462\u2013469. doi: 10.1016/j.foodchem.2007.12.068.", "ArticleIdList": ["10.1016/j.foodchem.2007.12.068", "26003373"]}, {"Citation": "Abraham K., Wohrlin F., Lindtner O., Heinemeyer G., Lampen A. Toxicology and risk assessment of coumarin: Focus on human data. Mol. Nutr. Food Res. 2010;54:228\u2013239. doi: 10.1002/mnfr.200900281.", "ArticleIdList": ["10.1002/mnfr.200900281", "20024932"]}, {"Citation": "European Food Safety Authority Coumarin in flavourings and other food ingredients with flavouring properties\u2014Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) EFSA J. 2008;6:1\u201315.", "ArticleIdList": ["PMC10193634", "37213849"]}, {"Citation": "EMA Assessment Report on Panax ginseng, C.A. Meyer, Radix.  [(accessed on 29 December 2017)]; Available online:  http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2014/05/WC500167385.pdf."}, {"Citation": "EMA Assessment Report on Trigonella foenum-graecum L.; Semen.  [(accessed on 29 December 2017)]; Available online:  http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2011/04/WC500105228.pdf."}, {"Citation": "Biagi M., Pecorari R., Appendino G., Miraldi E., Magnano A.R., Governa P., Cettolin G., Giachetti D. Herbal Products in Italy\u202f: The Thin Line between Phytotherapy, Nutrition and Parapharmaceuticals\u202f; A Normative Overview of the Fastest Growing Market in Europe. Pharmaceuticals. 2016;9:65. doi: 10.3390/ph9040065.", "ArticleIdList": ["10.3390/ph9040065", "PMC5198040", "27801865"]}]}], "History": [{"Year": "2017", "Month": "11", "Day": "29"}, {"Year": "2017", "Month": "12", "Day": "30"}, {"Year": "2018", "Month": "1", "Day": "1"}, {"Year": "2018", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["29300317", "PMC6017385", "10.3390/molecules23010105", "molecules23010105"]}}]}